New developments in the treatment of psoriasis

被引：39

作者：

Lebwohl, M ^{[1
]}

机构：

[1] Mt Sinai Med Ctr, Dept Dermatol, New York, NY 10029 USA

来源：

ARCHIVES OF DERMATOLOGY | 2002年 / 138卷 / 05期

关键词：

D O I：

10.1001/archderm.138.5.686

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：686 / 688

页数：3

共 14 条

[1] Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].

Chaudhari, U ;

Romano, P ;

Mulcahy, LD ;

Dooley, LT ;

Baker, DG ;

Gottlieb, AB .

LANCET, 2001, 357 (9271) :1842-1847

[2] Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes [J].

Ellis, CN ;

Krueger, GG .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (04) :248-255

[3] Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis [J].

Gottlieb, A ;

Krueger, JG ;

Bright, R ;

Ling, M ;

Lebwohl, M ;

Kang, S ;

Feldman, S ;

Spellman, M ;

Wittkowski, K ;

Ochs, HD ;

Jardieu, P ;

Bauer, R ;

White, M ;

Dedrick, R ;

Garovoy, M .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) :428-435

[4] Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

[5] Anti-CD11a treatment for psoriasis concurrently increases circulating T-cells and decreases plaque T-cells, consistent with inhibition of cutaneous T-cell trafficking [J].

Krueger, J ;

Gottlieb, A ;

Miller, B ;

Dedrick, R ;

Garovoy, M ;

Walicke, P .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (02) :333-333

[6] Cyclosporine consensus conference: With emphasis on the treatment of psoriasis [J].

Lebwohl, M ;

Ellis, C ;

Gottlieb, A ;

Koo, J ;

Krueger, G ;

Linden, K ;

Shupack, J ;

Weinstein, G .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (03) :464-475

[7] Long-term low-dose cyclosporine therapy for severe psoriasis: Effects on renal function and structure [J].

Lowe, NJ ;

Wieder, JM ;

Rosenbach, A ;

Johnson, K ;

Kunkel, R ;

Bainbridge, C ;

Bourget, T ;

Dimov, I ;

Simpson, K ;

Glass, E ;

Grabie, MT .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (05) :710-719

[8] NEUTROPENIA DUE TO LOW-DOSE METHOTREXATE THERAPY FOR PSORIASIS AND RHEUMATOID-ARTHRITIS MAY BE FATAL [J].

MAYALL, B ;

POGGI, G ;

PARKIN, JD .

MEDICAL JOURNAL OF AUSTRALIA, 1991, 155 (07) :480-484

[9] Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial [J].

Mease, PJ ;

Goffe, BS ;

Metz, J ;

VanderStoep, A ;

Finck, B ;

Burge, DJ .

LANCET, 2000, 356 (9227) :385-390

[10] The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody [J].

Papp, K ;

Bissonnette, R ;

Krueger, JG ;

Carey, W ;

Gratton, D ;

Gulliver, WP ;

Lui, H ;

Lynde, CW ;

Magee, A ;

Minier, D ;

Ouellet, JP ;

Patel, P ;

Shapiro, J ;

Shear, NH ;

Kramer, S ;

Walicke, P ;

Bauer, R ;

Dedrick, RL ;

Kim, SS ;

White, M ;

Garovoy, MR .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (05) :665-674

← 1 2 →